External medicine for treating beriberi

A technology for external use of drugs and beriberi, applied in the direction of drug combinations, medical preparations containing active ingredients, pharmaceutical formulas, etc., can solve problems such as unsatisfactory treatment effects, and achieve the effect of avoiding allergic symptoms and treating beriberi

Inactive Publication Date: 2013-12-04
王树庆
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented combination of different medications works differently depending on how they work together with each other. It achieves this by either giving them an effect or reducing their side-effects altogether. These combinations are used regularly over time without causing any harmful reactions that may occur during use. They also have certain benefits such as improving healing rates from sore feet caused by sweaty legs syndrome (SBS), increasing body temperature levels due to excessive perspiration, making joint pain worse after exercise, etc., which could lead to better recovery times when treated properly.

Problems solved by technology

This patented technical problem addressed in this patents relates to athleteries feet that are prone to being affected with various diseases such as sweaty legs due to their ability to stay dry over an extended period without getting sick from germs on them. Current treatments have limitations because they can cause skin irritation when used repeatedly after having been exposed to these conditions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Example 1: An external medicine for treating beriberi, the raw material composition and weight ratio are:

[0015] Alum 5g, camphor 5g, sulfur 5g, borneol 5g, boric acid powder 3g, realgar 3g, calcined gypsum 3g, metronidazole 1.7g, dermatitis 1.7g, clotrimazole 1.7g, tannic acid 1.7g, nitrofurazone 1.7g, Benzoic acid 1.7g, salicylic acid 1.7g.

Embodiment 2

[0016] Example 2: An external medicine for treating athlete's foot, the raw material composition and weight ratio are:

[0017] Alum 3g, camphor 3g, sulfur 3g, borneol 3g, boric acid powder 1g, realgar 1g, calcined gypsum 1g, metronidazole 0.5g, piyanping 0.5g, clotrimazole 0.5g, tannic acid 0.5g, nitrofurazone 0.5g, Benzoic acid 0.5g, salicylic acid 0.5g.

Embodiment 3

[0018] Example 3: An external medicine for treating beriberi, the raw material composition and weight ratio are:

[0019] Alum 7g, Camphor 7g, Sulfur 7g, Borneol 7g, Boric Acid Powder 6g, Realgar 6g, Calcined Gypsum 6g, Metronidazole 3g, Piyanping 3g, Clotrimazole 3g, Tannic Acid 3g, Nitrofurazone 3g, Benzoic Acid 3g, Willow Acid 3g

[0020] In the above embodiments, the powder or ointment can be made into powder or ointment according to the conventional method, and used for external application, once a day, the application area is slightly larger than the affected area, seven days is a course of treatment, one course of treatment can be cured, and the severely ill patients can be cured appropriately.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an external medicine for treating beriberi. The external medicine is characterized by be prepared from the following raw materials by weight: 3-7 g alumen, 3-7 g mothball, 3-7 g sulfur, 3-7 g borneol, 1-6 g boric acid powder, 1-6 g realgar, 1-6 g calcined plaster, 0.5-3 g metronidazole, 0.5-3 g compound dexamethasone acetate and 0.5-3 g clotrimazole. All the medicines perform functions together to realize combined internal and external therapy, avoid allergy symptoms, effectively treat beriberi, and achieve the effects of clearing heat, drying dampness, detoxifying, relieving itching, activating blood circulation and promoting granulation.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner 王树庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap